Government approves closure of BIBCOL

Regulatory & Legal View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.6%Reaction day

₹15.25

prior close

₹15.27

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-5.4% vs market

Pharmaceuticals peers, median of 173sector+1.0%-5.6% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-3.0

15m

-1.8

30m

-3.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.6+0.8-5.4+1.0-5.6

Next day

-7.5+2.5-10.0+1.8-9.3

-10.4+2.3-12.8+2.3-12.7

-8.3+2.8-11.1+2.0-10.3

-12.1+4.1-16.2+2.8-14.9

-14.0+2.5-16.5+1.9-15.9

-25.8+1.2-27.0+0.3-26.2

15d

-42.3-0.8-41.5-3.0-39.3

-37.4-1.7-35.7-4.3-33.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Government of India has approved the closure of Bharat Immunologicals and Biologicals Corporation (BIBCOL), a public sector company under the Department of Biotechnology, Ministry of Science and Technology. The decision is based on a communication dated April 11 from the Department of Biotechnology.

Likely market impact

Major negative for shareholders. Government's closure approval could lead to delisting and significant losses for investors.